Showing results (21-30 of 96) with videos related to
Sort By:
Pageof 10
The AAPS Journal|December 18, 2012
The twofold advantage of the amorphous form as an oral drug delivery practice for lipophilic compounds: increased apparent solubility and drug flux through the intestinal membraneArik Dahan, Avital Beig, Viktoriya Ioffe-Dahan, et al.Molecular Pharmaceutics|June 12, 2010
Enabling the intestinal absorption of highly polar antiviral agents: ion-pair facilitated membrane permeation of zanamivir heptyl ester and guanidino oseltamivirJonathan M Miller, Arik Dahan, Deepak Gupta, et al.Journal of Child Neurology|March 29, 2006
Behavioral therapy for treatment of stereotypic movements in nonautistic childrenJonathan M Miller, Harvey S Singer, Dana D Bridges, et al.Health & Place|June 17, 2020
Are low income children more physically active when they live in homes with bigger yards? A longitudinal analysis of the NET-Works StudyJonathan M Miller, Yingling Fan, Nancy E Sherwood, et al.The AAPS Journal|February 17, 2017
Advantageous Solubility-Permeability Interplay When Using Amorphous Solid Dispersion (ASD) Formulation for the BCS Class IV P-gp Substrate Rifaximin: Simultaneous Increase of Both the Solubility and the PermeabilityAvital Beig, Noa Fine-Shamir, David Lindley, et al.Journal of Controlled Release : Official Journal of the Controlled Release Society|March 7, 2009
Quasi-equilibrium analysis of the ion-pair mediated membrane transport of low-permeability drugsJonathan M Miller, Arik Dahan, Deepak Gupta, et al.Molecular Pharmaceutics|May 29, 2012
A win-win solution in oral delivery of lipophilic drugs: supersaturation via amorphous solid dispersions increases apparent solubility without sacrifice of intestinal membrane permeabilityJonathan M Miller, Avital Beig, Robert A Carr, et al.Journal of Pharmaceutical Sciences|December 30, 2009
The solubility-permeability interplay in using cyclodextrins as pharmaceutical solubilizers: mechanistic modeling and application to progesteroneArik Dahan, Jonathan M Miller, Amnon Hoffman, et al.Molecular Pharmaceutics|January 28, 2012
The solubility-permeability interplay when using cosolvents for solubilization: revising the way we use solubility-enabling formulationsJonathan M Miller, Avital Beig, Robert A Carr, et al.Progress in Pediatric Cardiology|August 25, 2020
Severe cardiac dysfunction in a patient with multisystem inflammatory syndrome in children associated with COVID-19: Retrospective diagnosis of a puzzling presentation. A case reportDaniel Vari, Jonathan M Miller, Neil Rellosa, et al.Pageof 10